🇺🇸 KRYS — Krystal Biotech, Inc.

Salud Compra fuerte
← Volver

Precio actual

300,88 USD

Máx. histórico

378,15

130 días

Caída desde máximo

-20,43%

Rango 52 semanas

192,52 – 382,54

Variación hoy

+0,21%

Cierre anterior

300,25

Rango de hoy

297,52 – 305,60

Volumen hoy

234.199

Peor caída histórica

-53,42%

01/03/2021 → 26/11/2021

Recuperado en 3 días

Volatilidad anualizada ⓘ

73,03%

Información
Nombre completo
Krystal Biotech, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
295
PER ⓘ
40,88 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
388,22 USD (puede no estar actualizado)
Primera cotización
20/09/2017
Precio actualizado
hace 22 horas
Sobre la empresa

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
23/02/2023 78,30 78,88 76,86 78,24 -0,01% 2,58% 99.100
22/02/2023 77,54 78,88 76,96 78,25 +0,89% 2,48% 129.500
21/02/2023 78,17 79,00 76,83 77,56 -0,88% 2,77% 182.200
17/02/2023 74,70 79,00 73,95 78,25 +5,23% 6,76% 148.100
16/02/2023 73,34 74,75 72,98 74,36 +1,16% 2,41% 206.300
15/02/2023 74,47 75,89 71,10 73,51 -1,99% 6,44% 239.000
14/02/2023 77,56 78,64 74,71 75,00 -3,60% 5,07% 217.400
13/02/2023 76,63 78,27 75,58 77,80 +1,33% 3,52% 79.500
10/02/2023 76,97 77,67 75,85 76,78 +0,05% 2,36% 100.400
09/02/2023 78,56 78,62 75,83 76,74 -1,67% 3,56% 118.200
08/02/2023 80,15 80,48 78,00 78,04 -2,89% 3,09% 177.300
07/02/2023 80,15 80,44 78,40 80,36 +0,51% 2,55% 118.200
06/02/2023 79,84 80,80 78,44 79,95 -0,32% 2,96% 120.900
03/02/2023 79,66 81,88 79,05 80,21 -0,46% 3,55% 155.600
02/02/2023 82,06 83,30 79,08 80,58 -1,38% 5,14% 273.500
01/02/2023 83,38 83,56 80,52 81,71 -1,70% 3,64% 150.800
31/01/2023 83,33 84,37 82,19 83,12 +0,40% 2,62% 168.700
30/01/2023 83,82 84,65 81,51 82,79 -1,70% 3,75% 93.700
27/01/2023 83,82 85,21 82,63 84,22 +0,29% 3,07% 97.900
26/01/2023 84,50 85,47 82,81 83,98 -0,34% 3,15% 151.900
25/01/2023 82,88 84,91 81,74 84,27 +1,24% 3,82% 163.000
24/01/2023 79,73 83,86 79,73 83,24 +4,34% 5,18% 158.600
23/01/2023 81,41 81,53 79,68 79,78 -1,79% 2,27% 145.700
20/01/2023 80,24 81,48 78,00 81,23 +2,81% 4,33% 208.600
19/01/2023 77,85 80,79 76,39 79,01 +1,09% 5,65% 160.400
18/01/2023 81,22 82,18 77,40 78,16 -3,16% 5,89% 179.100
17/01/2023 83,08 83,20 80,13 80,71 -2,70% 3,70% 178.500
13/01/2023 82,41 85,10 82,08 82,95 +0,12% 3,66% 184.700
12/01/2023 76,24 83,49 75,66 82,85 +9,23% 10,27% 195.700
11/01/2023 72,83 76,06 72,01 75,85 +3,82% 5,56% 171.800